was a big mover last session, with shares rising nearly 9% on the
day. The move came on solid volume too, with far more shares
changing hands than in a normal session. This reverses the recent
trend of Intrexon, as the stock is now down over 14% in the past
one-month time frame.
This biotechnology company saw one positive estimate revision in
the last 30 days and its Zacks Consensus Estimate also moved higher
over the same time frame. This implies that Intrexon holds
potential for more solid trading going forward. So make sure to
keep an eye on this stock to see if Friday's rally can convert into
greater strength down the road.
Intrexon currently has a Zacks Rank #4 (Sell) while its
Some better-ranked stocks worth considering in the Healthcare
BG Medicine, Inc.
ICON Public Limited Company
Charles River Laboratories International, Inc.
). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
BG MEDICINE INC (BGMD): Free Stock Analysis
CHARLES RVR LAB (CRL): Free Stock Analysis
ICON PLC (ICLR): Free Stock Analysis Report
INTREXON CORP (XON): Free Stock Analysis Report
To read this article on Zacks.com click here.